Wordt geladen...
Front-Line and Salvage Therapies With Tyrosine Kinase Inhibitors and Other Treatments in Chronic Myeloid Leukemia
Chronic myeloid leukemia (CML) has been a model disease in the development of targeted therapies. After nearly 40 years of the recognition of the chromosomal abnormality that defines CML, specific therapy was developed, initially with imatinib mesylate, which has transformed our treatment algorithms...
Bewaard in:
| Gepubliceerd in: | J Clin Oncol |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society of Clinical Oncology
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4979134/ https://ncbi.nlm.nih.gov/pubmed/21220597 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.31.3619 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|